financetom
Business
financetom
/
Business
/
Santander books record Q3 profit as strong US unit offsets weaker Brazil
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Santander books record Q3 profit as strong US unit offsets weaker Brazil
Oct 29, 2025 1:17 AM

*

Q3 profit up 8% y/y to 3.5 bln euros vs forecasts of 3.34

bln

*

Q3 NII falls 1.1% y/y

*

Net profit in the US up 64%, falls 6% in Brazil

*

Says on track to meet full-year guidance targets

(Adds profitability ratios, targets in paragraphs 4-5, Chair

comments in paragraphs 6-7)

By Jesús Aguado

MADRID, Oct 29 (Reuters) - Spain's Santander bank

reported a 7.8% year-on-year rise in its third-quarter

net profit, saying a strong performance in its U.S. business

offset lower lending income and some weakness in Brazil.

The net profit of 3.5 billion euros ($4.08 billion) in the

July-September quarter reported by the euro zone's biggest bank

came above the 3.39 billion euros expected by analysts in a

Reuters poll and was the sixth consecutive record-high quarterly

result.

A rise of 4.3% in fees and of 0.87% in revenues compensated

a decline of 1.1% in lending income, the bank said.

Santander's measure of profitability, tangible-equity ratio

(ROTE) after the impact of additional Tier 1 (AT1) capital

instruments, remained unchanged at 16.2% compared to the

previous quarter. The bank said it was on track to meet its

target of around 16.5% for this year and its full-year revenue

target of around 62 billion euros.

Executive Chair Ana Botin said Santander's geographical

spread - it operates in 10 core markets in Europe and the

Americas - would act as a stabiliser in an uncertain global

environment.

"Looking ahead, we are on track to meet all our 2025 targets

and, amid continued geopolitical and market uncertainty, we are

confident we will continue delivering further profitable

growth," Botin said in a statement.

Underlying net profit in the U.S., its fifth-largest market,

rose 64% supported by higher lending income and higher fees from

its corporate and investment banking business.

The bank has benefited in the past from higher interest

rates, while growth in key Latin American markets has given it

an edge over more Europe-dependent rivals.

But it was hit by currency depreciations in some of its

emerging markets, such as Brazil, where the real's devaluation

drove the underlying net profit down 5.9% in the quarter.

($1 = 0.8575 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: UBS' Credit Suisse Debt Draws Interest From Asset Management Firm
Update: Market Chatter: UBS' Credit Suisse Debt Draws Interest From Asset Management Firm
Jun 7, 2024
09:21 AM EDT, 06/07/2024 (MT Newswires) -- (Updates with UBS response in the last paragraph.) UBS' (UBS) defunct Credit Suisse's Eastern European debt has drawn interest from RBC BlueBay Asset Management, Bloomberg News reported Friday, citing RBC BlueBay executive Polina Kurdyavko. About 10 Credit Suisse emerging-market loans come to the market each week, ranging from $20 million to $200 million...
TotalEnergies and Air Products sign deal for green hydrogen delivery
TotalEnergies and Air Products sign deal for green hydrogen delivery
Jun 7, 2024
June 7 (Reuters) - French oil and gas major TotalEnergies said on Friday it had signed a deal with U.S. industrial gases company Air Products and Chemicals ( APD ) for delivery of green hydrogen. The companies signed a 15-year agreement for the annual supply in Europe of 70,000 tons of green hydrogen starting in 2030, TotalEnergies said in a...
ChromaDex Says US FDA Grants NRC Orphan Drug, Rare Pediatric Disease Designations -- Shares Climb Pre-Bell
ChromaDex Says US FDA Grants NRC Orphan Drug, Rare Pediatric Disease Designations -- Shares Climb Pre-Bell
Jun 7, 2024
09:24 AM EDT, 06/07/2024 (MT Newswires) -- ChromaDex ( CDXC ) said Friday that the US Food & Drug Administration has granted orphan-drug designation and rare pediatric disease designation for NRC, the company's drug candidate to treat Ataxia Telangiectasia. Ataxia Telangiectasia is a rare, progressive disease that is characterized by neurological and immunological symptoms. The company said it plans to...
Semtech Names Hong Hou President, Chief Executive Officer; Shares Fall
Semtech Names Hong Hou President, Chief Executive Officer; Shares Fall
Jun 7, 2024
09:21 AM EDT, 06/07/2024 (MT Newswires) -- Semtech ( SMTC ) said Friday that Hong Hou has been named president and chief executive officer, effective June 6, succeeding Paul Pickle. Hou is a current member of the Semtech ( SMTC ) board. Semtech ( SMTC ) said Pickle's departure resulted from differences between the board and Mr. Pickle on how...
Copyright 2023-2026 - www.financetom.com All Rights Reserved